🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting. avacta.com/avacta-therape… #AVCT

In the latest episode of the R&D Spotlight series we look at some recent IP that informs the basis of our second drug, AVA6103. #AVCT avacta.wistia.com/medias/8f6ompc…

The preclinical and translational data being presented on two posters by the Avacta team today at #AACR25 are now available to view on our website at avacta.com/about/scientif…. A third poster, on safety and efficacy data for AVA6000, will go live at the same time tomorrow. #AVCT

A busy start for the #AVCT team at #AACR25.

Avacta today announces that Dr. Trevor Nicholls, one of the Group’s non-executive directors, is retiring from the Board with effect from April 30, 2025. avacta.com/board-change/ #AVCT

Another busy poster session for the team today at #AACR25. The poster being presented today can also be downloaded from our website now. avacta.com/about/scientif…

We are delighted to have been shortlisted for the Best Technology Award at the European Mediscience Awards 2025. #EMA25 #AVCT mediscience-event.co.uk/nominations-ov…

Avacta will announce its audited preliminary results for year ended December 31, 2024 on May 29, 2025. avacta.com/notice-of-resu… #AVCT

Read the new Citeline article, 'The pre|CISION Approach: How Avacta Is Making Toxic Cancer Drugs Safe And More Effective', here: insights.citeline.com/in-vivo/innova… #AVCT

Avacta announces the appointments of David Bryant and Richard Hughes as Non-Executive Directors with immediate effect avacta.com/board-appointm…

Update on timing of preliminary results announcement. avacta.com/update-on-timi… #AVCT

Preliminary Results for the Year Ended December 31, 2024 avacta.com/wp-content/upl… #AVCT

Couldn't make today's live presentation with AVACTA GROUP PLC? #AVCT Avacta No problem! Catch up here: youtube.com/watch?v=ajabya…

Key 25/26 data from Avacta's lead #preCISION progs: 1) #AVA6000 (FAP-Dox) initial #SGC data late-25 & #TNBC data H126; subject to funding, Phase II in both planned for H126. 2) AVA6103 (FAP-EXd) IND sub late-25, Phase I start Q126 & 1st data Q426 #AVCT trinitydelta.org/companies/avac…